DM Clinical Research, Indianapolis

The trials here

What the 5 trials at this site are about, from their registry records.

Conditions

• Obesity3 trials
• Type 2 diabetes3 trials
• COPD1 trial
• Migraine1 trial

Phase

• Phase 34 trials
• Phase 21 trial

Status

• Recruiting3 trials
• Not yet recruiting2 trials

Lead sponsor

• Eli Lilly and Company3 trials
• Expedition Therapeutics, Inc1 trial
• TriGemX Bio, Inc.1 trial

Running trials

• Not yet recruiting

  A Study of EloraTZP in Adult Participants With Obesity Without Type 2 Diabetes

  NCT07881432· Phase 3· Eli Lilly and Company· Source

  Contact: Brandon Essink (principal investigator)

• Recruiting

  A Study of EloraTZP in Adult Participants With Obesity or Overweight and Type 2 Diabetes

  NCT07881458· Phase 3· Eli Lilly and Company· Source

  Contact: Brandon Essink (principal investigator)

• Recruiting

  A Study to Assess the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine

  NCT07816367· Phase 3· TriGemX Bio, Inc.· Source

  Contact: Brandon Essink

• Recruiting

  To Evaluate the Effect of EXPD-101/FXS7553 Compared With Placebo in Patients With COPD Over 52 Weeks of Treatment

  NCT07684820· Phase 2· Expedition Therapeutics, Inc· Source

  Contact: Stephanie Samayoa

• Recruiting

  A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes

  NCT07282600· Phase 3· Eli Lilly and Company· Source

  Contact: Brandon Essink (principal investigator)

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Obesity3 recruiting
• Type 2 diabetes3 recruiting
• COPD1 recruiting
• Migraine1 recruiting